The Indian Pharmaceutical Alliance (IPA) represents research-based National Pharmaceutical Companies.
Poke Me: How policymakers killed off a once-thriving sector of India's much-vaunted pharma industry.
Generics vs big pharma, reloaded.
Increasing the period of surveillance data may delay entry of generic drugs.
New drugs may soon be considered 'new' for 10 years instead of 4.
The United Nations Secretary-General's High-Level Panel on Access to Medicines report- Promoting innovation and access to health technologies.
India Pharmaceutical Forum 2017